http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2583244-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6af3e27cdfa41f1e655df4a7a3393477
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2005-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c3f80b06d155cf88834c98331f0a8c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e0342f444329dfbb447a18d057d028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_333b96783df002729362b3580e6d2867
publicationDate 2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2583244-A1
titleOfInvention Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
abstract A method for reducing mortality associated with GVHD by treating the patent with an oral BDP regimen that involves co-administration of: 1) a high dose of prednisone (about 1-2 mg/kg/day) for about 10 days, which is then tapered rapidly over the following 7 days to a physiological replacement dose of about 0.0625 mg/kg/day for the remainder of the treatment, and 2) about 4 - 12 mg oral BDP q.i.d. for about 50 days, where the BDP is administered in both immediate release and enteric coated preparations. Another method is for treating leukemia by performing hematopoietic cell transplantation followed by said regimen. A significant reduction in patient mortality is observed 200 days after the start of these treatments
priorityDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505468
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID636374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12564590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21872322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID294739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452523935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421888096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407275646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426121993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71414

Total number of triples: 79.